Northeast Pharmaceutical Group Company Overview

  • Year Founded
  • 1946

Year Founded

  • Status
  • Public

  • Employees
  • 5,727

Employees

  • Stock Symbol
  • 000597

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.60
  • (As of Friday Closing)

Northeast Pharmaceutical Group Company General Information

Description

Northeast Pharmaceutical Group Co Ltd is engaged in the production and distribution of ammonium phosphate, sulfuric acid, cement, compound fertilizer, bromine, raw salt, and diammonium phosphate.

Contact Information

Formerly Known As
Northeast Pharmaceutical General Factory
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Number 8, Kunminghu Street
  • Economic Technology Development District
  • Shenyang, Liaoning 110027
  • China
+86 024
Primary Industry
Pharmaceuticals
Other Industries
Other Consumer Non-Durables
Distributors (Healthcare)
Stock Exchange
SHE
Corporate Office
  • Number 8, Kunminghu Street
  • Economic Technology Development District
  • Shenyang, Liaoning 110027
  • China
+86 024

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Northeast Pharmaceutical Group Company Stock Performance

As of 20-Nov-2026, Northeast Pharmaceutical Group Company’s stock price is $0.60. Its current market cap is $863M with 1.43B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.60 $0.62 $0.60 - $0.84 $863M 1.43B 12.7M $0.02

Northeast Pharmaceutical Group Company Financials Summary

As of 30-Sep-2026, Northeast Pharmaceutical Group Company has a trailing 12-month revenue of $936M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 688,763 789,617 654,493 797,220
Revenue 936,085 983,805 1,045,585 1,165,133
EBITDA 23,888 112,056 153,549 139,403
Net Income 27,487 36,164 57,118 50,666
Total Assets 1,954,941 1,842,147 1,978,902 2,154,678
Total Debt 271,962 306,828 222,979 312,959
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Northeast Pharmaceutical Group Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Northeast Pharmaceutical Group Company‘s full profile, request access.

Request a free trial

Northeast Pharmaceutical Group Company Patents

Northeast Pharmaceutical Group Company Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026032207-A1 Humanized antibody targeting tfr1 and use thereof Pending 09-Aug-2024
JP-2024545136-A Anti-tfr1 antibody mab11-22.1 conjugate for cancer treatment Active 06-Dec-2021
AU-2022404416-A1 Anti-tfr1 antibody mab11-22.1 conjugates for cancer treatment Pending 06-Dec-2021
EP-4444752-A1 Anti-tfr1 antibody mab11-22.1 conjugates for cancer treatment Pending 06-Dec-2021
EP-4444752-A4 Anti-tfr1 antibody mab11-22.1 conjugates for cancer treatment Pending 06-Dec-2021 A61K40/11
To view Northeast Pharmaceutical Group Company’s complete patent history, request access »

Northeast Pharmaceutical Group Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Northeast Pharmaceutical Group Company Acquisitions (1)

Northeast Pharmaceutical Group Company’s most recent deal was a Merger/Acquisition with DCTY Biotech for . The deal was made on 09-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DCTY Biotech 09-Nov-2024 Merger/Acquisition Biotechnology
To view Northeast Pharmaceutical Group Company’s complete acquisitions history, request access »

Northeast Pharmaceutical Group Company ESG

Risk Overview

Risk Rating

Updated September, 30, 2025

46.18 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Pharmaceuticals

Subindustry

of 406

Rank

Percentile

To view Northeast Pharmaceutical Group Company’s complete esg history, request access »

Northeast Pharmaceutical Group Company FAQs

  • When was Northeast Pharmaceutical Group Company founded?

    Northeast Pharmaceutical Group Company was founded in 1946.

  • Where is Northeast Pharmaceutical Group Company headquartered?

    Northeast Pharmaceutical Group Company is headquartered in Shenyang, China.

  • What is the size of Northeast Pharmaceutical Group Company?

    Northeast Pharmaceutical Group Company has 5,727 total employees.

  • What industry is Northeast Pharmaceutical Group Company in?

    Northeast Pharmaceutical Group Company’s primary industry is Pharmaceuticals.

  • Is Northeast Pharmaceutical Group Company a private or public company?

    Northeast Pharmaceutical Group Company is a Public company.

  • What is Northeast Pharmaceutical Group Company’s stock symbol?

    The ticker symbol for Northeast Pharmaceutical Group Company is 000597.

  • What is the current stock price of Northeast Pharmaceutical Group Company?

    As of 20-Nov-2026 the stock price of Northeast Pharmaceutical Group Company is $0.60.

  • What is the current market cap of Northeast Pharmaceutical Group Company?

    The current market capitalization of Northeast Pharmaceutical Group Company is $863M.

  • What is Northeast Pharmaceutical Group Company’s current revenue?

    The trailing twelve month revenue for Northeast Pharmaceutical Group Company is $936M.

  • What is Northeast Pharmaceutical Group Company’s annual earnings per share (EPS)?

    Northeast Pharmaceutical Group Company’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process